Stockscreener 앱 받기
19.03
1.39%
0.26
시간 외 거래:
19.03
Baxter International Inc 주식(BAX)의 최신 뉴스
Baxter International earnings preview: What to expect - MSN
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
First Pacific Advisors's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Inc. stock (US0673431090): governance changes and board size reset in focus - AD HOC NEWS
Baxter International Inc. stock (US0673431090): spin-off hangover meets restructuring push - AD HOC NEWS
Baxter International Inc (BAX) Stock Up 3.0% and Still Undervalued -- GF Score: 61/100 - GuruFocus
Baxter Board Size Reset Puts Governance Changes In Focus For Investors - simplywall.st
Baxter stock (US0673431090): FDA update puts focus on hospital-device demand - AD HOC NEWS
TD Cowen Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $20 - Moomoo
BAX (NYSE: BAX) affiliate files notice listing prior open-market purchases - Stock Titan
Baxter International Inc. (BAX) Stock Analysis: Exploring a 27.83% Potential Upside Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
Is Baxter International (BAX) Pricing Reflect A Turn After Steep Multi Year Share Price Declines - Sahm
Baxter hosts manufacturing forum - Manufacturers' Monthly
Baxter International stock (US0673431090): News flow turns after fresh market moves - AD HOC NEWS
Baxter International stock (US0718131099): Q1 update highlights mixed sales and margin pressure - AD HOC NEWS
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
BofA Securities Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $24 - Moomoo
Baxter International Inc. stock (US0673431090): pharma supplier in focus after latest price swings - AD HOC NEWS
Baxter International shareholders approve board slate, pay and incentive plan at annual meeting - MSN
Baxter International stock (US0673431090): Gains 2.05% to $17.89 - AD HOC NEWS
Baxter International Inc. stock (US0673431090): Down 3.2% amid conference presentation - AD HOC NEWS
Baxter International stock outlook: Is Wall Street bullish or bearish? - MSN
First Pacific Advisors' Strategic Moves: Baxter International In - GuruFocus
First Pacific Advisors' Strategic Moves: Baxter International Inc. Takes Center Stage - GuruFocus
Baxter International Inc (BAX) Stock Down 3.2% -- Now Undervalued? GF Score: 66/100 - GuruFocus
Artisan Value Income Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Transcript : Baxter International Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 11 - marketscreener.com
Baxter International Inc. stock (US0673431090): Recent 2% price gain on NYSE - AD HOC NEWS
Baxter International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Baxter International Inc stock (US0718131099): Shares drop 2.56% to $17.53 - AD HOC NEWS
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Rare Hemophilia Factors Market Is Going to Boom |• Baxter International • Novo Nordisk • Pfizer - openPR.com
Baxter International Inc. stock (US0673431090): Q1 2026 earnings beat consensus - AD HOC NEWS
Manning & Napier Advisors LLC Sells 84,998 Shares of Baxter International Inc. $BAX - MarketBeat
Precision Trading with Baxter International Inc. (BAX) Risk Zones - Stock Traders Daily
Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting - Barchart.com
Baxter International Inc. stock (US0673431090): Governance shake?up and earnings pressure in focus - AD HOC NEWS
Baxter International updates executive severance plan and amends bylaws after annual meeting - Investing.com India
Baxter Updates Executive Severance Plan and Governance Framework - TipRanks
Baxter (NYSE: BAX) expands severance protections and adds 20M incentive shares - Stock Titan
Infusion Therapy Market Is Going to Boom | Baxter International, B. Braun Melsungen AG, Fresenius Kabi AG - openPR.com
Baxter International Still Has A Path To Upside - Seeking Alpha
Director at Baxter (NYSE: BAX) receives 12,836 fully vested share award, now holds 37,076 - Stock Titan
Baxter (BAX) director Amy McBride receives 12,836-share fully vested stock grant - Stock Titan
Director at Baxter (NYSE: BAX) awarded 12,836 shares, holds 34,994 - Stock Titan
Baxter International (BAX) director awarded 12,836 fully vested shares - Stock Titan
Baxter (BAX) board chair David Brent Shafer receives 12,836-share stock grant - Stock Titan
Director Michael McDonnell of Baxter (NYSE: BAX) receives 12,836-share fully vested grant - Stock Titan
Director Jeffrey A. Craig receives 12,836 Baxter (BAX) shares in grant - Stock Titan
Baxter (NYSE: BAX) director awarded 12,836 fully vested shares in Form 4 - Stock Titan
MSN Money - MSN
Becton Dickinson at 13x Earnings: MedTech’s Most Mispriced Compounder - Investing.com
Baxter International Inc. stock rises Wednesday, still underperforms market - MarketWatch
FMR LLC reports 9.0% stake in Baxter International (BAX) — 46.3M shares - Stock Titan
0.21%
1.78%
자본화:
|
볼륨(24시간):